Loading…
Cost-effectiveness of the HIT programme in patients with schizophrenia and persistent auditory hallucinations
Objective: To examine the cost‐effectiveness of Hallucination focused Integrative Treatment (HIT) in patients with schizophrenia and a history of persistent auditory hallucinations. Method: Costs, in and outside the health care sector, and outcomes were registered prospectively during a period of...
Saved in:
Published in: | Acta psychiatrica Scandinavica 2003-05, Vol.107 (5), p.361-368 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4332-de6491562b2c503e4731e01acdd8439c85e6f641d0fa6bafe8d2e427647749f43 |
---|---|
cites | cdi_FETCH-LOGICAL-c4332-de6491562b2c503e4731e01acdd8439c85e6f641d0fa6bafe8d2e427647749f43 |
container_end_page | 368 |
container_issue | 5 |
container_start_page | 361 |
container_title | Acta psychiatrica Scandinavica |
container_volume | 107 |
creator | Stant, A. D. TenVergert, E. M. Groen, H. Jenner, J. A. Nienhuis, F. J. van de Willige, G. Wiersma, D. |
description | Objective: To examine the cost‐effectiveness of Hallucination focused Integrative Treatment (HIT) in patients with schizophrenia and a history of persistent auditory hallucinations.
Method: Costs, in and outside the health care sector, and outcomes were registered prospectively during a period of 18 months for patients who received the HIT programme and for patients in the care as usual (CAU) condition. The Positive and Negative Syndrome Scale (PANSS) was used as main outcome measure in the cost‐effectiveness analysis. Bootstrap analyses provided additional information on the skewly distributed costs.
Results: Mean costs per patient in the HIT group ($18 237) were lower than the mean costs per patient in the CAU group ($21 436). Results of the PANSS were slightly in favour of the HIT group.
Conclusion: There appears to be no significant cost‐effectiveness advantage of the HIT programme over CAU. Additional analyses indicated that future application of the HIT programme will, in most cases, lead to a reduction of (non) medical costs. |
doi_str_mv | 10.1034/j.1600-0447.2003.00102.x |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73268612</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73268612</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4332-de6491562b2c503e4731e01acdd8439c85e6f641d0fa6bafe8d2e427647749f43</originalsourceid><addsrcrecordid>eNqNkEuP0zAURi0EYsrAX0DewC7h-hEnWbAYVdCONAIkBoHYWK5zQ1zywk6Yll-PQ6uZLSu_znf96RBCGaQMhHyzT5kCSEDKPOUAIgVgwNPDI7K6f3hMVhCvE1XCtwvyLIR9PGYMiqfkgvE84yD4inTrIUwJ1jXayf3GHkOgQ02nBun2-paOfvjhTdchdT0dzeSwnwK9c1NDg23cn2FsPPbOUNNXdEQfXJgiQs1cuWnwR9qYtp2t62N06MNz8qQ2bcAX5_WSfHn_7na9TW4-bq7XVzeJlULwpEIlS5YpvuM2A4EyFwyBGVtVhRSlLTJUtZKsgtqonamxqDhKniuZ57Kspbgkr09zY_9fM4ZJdy5YbFvT4zAHnQuuCsV4BIsTaP0Qgsdaj951xh81A72o1nu9GNWLUb2o1v9U60OMvjz_Me86rB6CZ7cReHUGTLCmrb3prQsPnCxAlHwp-_bE3bkWj_9dQF-tP32Ou5hPTvnF_eE-b_xPrXKRZ_rrh42WavMdtptSF-IvCD6qOA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73268612</pqid></control><display><type>article</type><title>Cost-effectiveness of the HIT programme in patients with schizophrenia and persistent auditory hallucinations</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Stant, A. D. ; TenVergert, E. M. ; Groen, H. ; Jenner, J. A. ; Nienhuis, F. J. ; van de Willige, G. ; Wiersma, D.</creator><creatorcontrib>Stant, A. D. ; TenVergert, E. M. ; Groen, H. ; Jenner, J. A. ; Nienhuis, F. J. ; van de Willige, G. ; Wiersma, D.</creatorcontrib><description>Objective: To examine the cost‐effectiveness of Hallucination focused Integrative Treatment (HIT) in patients with schizophrenia and a history of persistent auditory hallucinations.
Method: Costs, in and outside the health care sector, and outcomes were registered prospectively during a period of 18 months for patients who received the HIT programme and for patients in the care as usual (CAU) condition. The Positive and Negative Syndrome Scale (PANSS) was used as main outcome measure in the cost‐effectiveness analysis. Bootstrap analyses provided additional information on the skewly distributed costs.
Results: Mean costs per patient in the HIT group ($18 237) were lower than the mean costs per patient in the CAU group ($21 436). Results of the PANSS were slightly in favour of the HIT group.
Conclusion: There appears to be no significant cost‐effectiveness advantage of the HIT programme over CAU. Additional analyses indicated that future application of the HIT programme will, in most cases, lead to a reduction of (non) medical costs.</description><identifier>ISSN: 0001-690X</identifier><identifier>EISSN: 1600-0447</identifier><identifier>DOI: 10.1034/j.1600-0447.2003.00102.x</identifier><identifier>PMID: 12752032</identifier><identifier>CODEN: APYSA9</identifier><language>eng</language><publisher>Oxford, UK: Munksgaard International Publishers</publisher><subject>Adult ; Associated treatments ; Biological and medical sciences ; Cost of Illness ; Cost Savings ; Cost-Benefit Analysis ; cost-benefit analysis (cost-effectiveness) ; costs and cost analysis ; Female ; hallucinations ; Hallucinations - economics ; Hallucinations - etiology ; Hallucinations - therapy ; Humans ; Male ; Medical sciences ; Middle Aged ; Netherlands ; Outcome Assessment (Health Care) - statistics & numerical data ; Patient Compliance ; Patient Satisfaction ; Program Evaluation ; Prospective Studies ; Psychiatric Status Rating Scales ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; schizophrenia ; Schizophrenia - complications ; Schizophrenia - economics ; Schizophrenia - therapy ; therapy ; Treatments</subject><ispartof>Acta psychiatrica Scandinavica, 2003-05, Vol.107 (5), p.361-368</ispartof><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4332-de6491562b2c503e4731e01acdd8439c85e6f641d0fa6bafe8d2e427647749f43</citedby><cites>FETCH-LOGICAL-c4332-de6491562b2c503e4731e01acdd8439c85e6f641d0fa6bafe8d2e427647749f43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14803924$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12752032$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stant, A. D.</creatorcontrib><creatorcontrib>TenVergert, E. M.</creatorcontrib><creatorcontrib>Groen, H.</creatorcontrib><creatorcontrib>Jenner, J. A.</creatorcontrib><creatorcontrib>Nienhuis, F. J.</creatorcontrib><creatorcontrib>van de Willige, G.</creatorcontrib><creatorcontrib>Wiersma, D.</creatorcontrib><title>Cost-effectiveness of the HIT programme in patients with schizophrenia and persistent auditory hallucinations</title><title>Acta psychiatrica Scandinavica</title><addtitle>Acta Psychiatr Scand</addtitle><description>Objective: To examine the cost‐effectiveness of Hallucination focused Integrative Treatment (HIT) in patients with schizophrenia and a history of persistent auditory hallucinations.
Method: Costs, in and outside the health care sector, and outcomes were registered prospectively during a period of 18 months for patients who received the HIT programme and for patients in the care as usual (CAU) condition. The Positive and Negative Syndrome Scale (PANSS) was used as main outcome measure in the cost‐effectiveness analysis. Bootstrap analyses provided additional information on the skewly distributed costs.
Results: Mean costs per patient in the HIT group ($18 237) were lower than the mean costs per patient in the CAU group ($21 436). Results of the PANSS were slightly in favour of the HIT group.
Conclusion: There appears to be no significant cost‐effectiveness advantage of the HIT programme over CAU. Additional analyses indicated that future application of the HIT programme will, in most cases, lead to a reduction of (non) medical costs.</description><subject>Adult</subject><subject>Associated treatments</subject><subject>Biological and medical sciences</subject><subject>Cost of Illness</subject><subject>Cost Savings</subject><subject>Cost-Benefit Analysis</subject><subject>cost-benefit analysis (cost-effectiveness)</subject><subject>costs and cost analysis</subject><subject>Female</subject><subject>hallucinations</subject><subject>Hallucinations - economics</subject><subject>Hallucinations - etiology</subject><subject>Hallucinations - therapy</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Netherlands</subject><subject>Outcome Assessment (Health Care) - statistics & numerical data</subject><subject>Patient Compliance</subject><subject>Patient Satisfaction</subject><subject>Program Evaluation</subject><subject>Prospective Studies</subject><subject>Psychiatric Status Rating Scales</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>schizophrenia</subject><subject>Schizophrenia - complications</subject><subject>Schizophrenia - economics</subject><subject>Schizophrenia - therapy</subject><subject>therapy</subject><subject>Treatments</subject><issn>0001-690X</issn><issn>1600-0447</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNqNkEuP0zAURi0EYsrAX0DewC7h-hEnWbAYVdCONAIkBoHYWK5zQ1zywk6Yll-PQ6uZLSu_znf96RBCGaQMhHyzT5kCSEDKPOUAIgVgwNPDI7K6f3hMVhCvE1XCtwvyLIR9PGYMiqfkgvE84yD4inTrIUwJ1jXayf3GHkOgQ02nBun2-paOfvjhTdchdT0dzeSwnwK9c1NDg23cn2FsPPbOUNNXdEQfXJgiQs1cuWnwR9qYtp2t62N06MNz8qQ2bcAX5_WSfHn_7na9TW4-bq7XVzeJlULwpEIlS5YpvuM2A4EyFwyBGVtVhRSlLTJUtZKsgtqonamxqDhKniuZ57Kspbgkr09zY_9fM4ZJdy5YbFvT4zAHnQuuCsV4BIsTaP0Qgsdaj951xh81A72o1nu9GNWLUb2o1v9U60OMvjz_Me86rB6CZ7cReHUGTLCmrb3prQsPnCxAlHwp-_bE3bkWj_9dQF-tP32Ou5hPTvnF_eE-b_xPrXKRZ_rrh42WavMdtptSF-IvCD6qOA</recordid><startdate>200305</startdate><enddate>200305</enddate><creator>Stant, A. D.</creator><creator>TenVergert, E. M.</creator><creator>Groen, H.</creator><creator>Jenner, J. A.</creator><creator>Nienhuis, F. J.</creator><creator>van de Willige, G.</creator><creator>Wiersma, D.</creator><general>Munksgaard International Publishers</general><general>Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200305</creationdate><title>Cost-effectiveness of the HIT programme in patients with schizophrenia and persistent auditory hallucinations</title><author>Stant, A. D. ; TenVergert, E. M. ; Groen, H. ; Jenner, J. A. ; Nienhuis, F. J. ; van de Willige, G. ; Wiersma, D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4332-de6491562b2c503e4731e01acdd8439c85e6f641d0fa6bafe8d2e427647749f43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adult</topic><topic>Associated treatments</topic><topic>Biological and medical sciences</topic><topic>Cost of Illness</topic><topic>Cost Savings</topic><topic>Cost-Benefit Analysis</topic><topic>cost-benefit analysis (cost-effectiveness)</topic><topic>costs and cost analysis</topic><topic>Female</topic><topic>hallucinations</topic><topic>Hallucinations - economics</topic><topic>Hallucinations - etiology</topic><topic>Hallucinations - therapy</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Netherlands</topic><topic>Outcome Assessment (Health Care) - statistics & numerical data</topic><topic>Patient Compliance</topic><topic>Patient Satisfaction</topic><topic>Program Evaluation</topic><topic>Prospective Studies</topic><topic>Psychiatric Status Rating Scales</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>schizophrenia</topic><topic>Schizophrenia - complications</topic><topic>Schizophrenia - economics</topic><topic>Schizophrenia - therapy</topic><topic>therapy</topic><topic>Treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stant, A. D.</creatorcontrib><creatorcontrib>TenVergert, E. M.</creatorcontrib><creatorcontrib>Groen, H.</creatorcontrib><creatorcontrib>Jenner, J. A.</creatorcontrib><creatorcontrib>Nienhuis, F. J.</creatorcontrib><creatorcontrib>van de Willige, G.</creatorcontrib><creatorcontrib>Wiersma, D.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Acta psychiatrica Scandinavica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stant, A. D.</au><au>TenVergert, E. M.</au><au>Groen, H.</au><au>Jenner, J. A.</au><au>Nienhuis, F. J.</au><au>van de Willige, G.</au><au>Wiersma, D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cost-effectiveness of the HIT programme in patients with schizophrenia and persistent auditory hallucinations</atitle><jtitle>Acta psychiatrica Scandinavica</jtitle><addtitle>Acta Psychiatr Scand</addtitle><date>2003-05</date><risdate>2003</risdate><volume>107</volume><issue>5</issue><spage>361</spage><epage>368</epage><pages>361-368</pages><issn>0001-690X</issn><eissn>1600-0447</eissn><coden>APYSA9</coden><abstract>Objective: To examine the cost‐effectiveness of Hallucination focused Integrative Treatment (HIT) in patients with schizophrenia and a history of persistent auditory hallucinations.
Method: Costs, in and outside the health care sector, and outcomes were registered prospectively during a period of 18 months for patients who received the HIT programme and for patients in the care as usual (CAU) condition. The Positive and Negative Syndrome Scale (PANSS) was used as main outcome measure in the cost‐effectiveness analysis. Bootstrap analyses provided additional information on the skewly distributed costs.
Results: Mean costs per patient in the HIT group ($18 237) were lower than the mean costs per patient in the CAU group ($21 436). Results of the PANSS were slightly in favour of the HIT group.
Conclusion: There appears to be no significant cost‐effectiveness advantage of the HIT programme over CAU. Additional analyses indicated that future application of the HIT programme will, in most cases, lead to a reduction of (non) medical costs.</abstract><cop>Oxford, UK</cop><pub>Munksgaard International Publishers</pub><pmid>12752032</pmid><doi>10.1034/j.1600-0447.2003.00102.x</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0001-690X |
ispartof | Acta psychiatrica Scandinavica, 2003-05, Vol.107 (5), p.361-368 |
issn | 0001-690X 1600-0447 |
language | eng |
recordid | cdi_proquest_miscellaneous_73268612 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Adult Associated treatments Biological and medical sciences Cost of Illness Cost Savings Cost-Benefit Analysis cost-benefit analysis (cost-effectiveness) costs and cost analysis Female hallucinations Hallucinations - economics Hallucinations - etiology Hallucinations - therapy Humans Male Medical sciences Middle Aged Netherlands Outcome Assessment (Health Care) - statistics & numerical data Patient Compliance Patient Satisfaction Program Evaluation Prospective Studies Psychiatric Status Rating Scales Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry schizophrenia Schizophrenia - complications Schizophrenia - economics Schizophrenia - therapy therapy Treatments |
title | Cost-effectiveness of the HIT programme in patients with schizophrenia and persistent auditory hallucinations |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T16%3A14%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cost-effectiveness%20of%20the%20HIT%20programme%20in%20patients%20with%20schizophrenia%20and%20persistent%20auditory%20hallucinations&rft.jtitle=Acta%20psychiatrica%20Scandinavica&rft.au=Stant,%20A.%20D.&rft.date=2003-05&rft.volume=107&rft.issue=5&rft.spage=361&rft.epage=368&rft.pages=361-368&rft.issn=0001-690X&rft.eissn=1600-0447&rft.coden=APYSA9&rft_id=info:doi/10.1034/j.1600-0447.2003.00102.x&rft_dat=%3Cproquest_cross%3E73268612%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4332-de6491562b2c503e4731e01acdd8439c85e6f641d0fa6bafe8d2e427647749f43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=73268612&rft_id=info:pmid/12752032&rfr_iscdi=true |